467 related articles for article (PubMed ID: 28984110)
1. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
A Armstrong R
Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
[TBL] [Abstract][Full Text] [Related]
2. Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).
Armstrong RA; Gearing M; Bigio EH; Cruz-Sanchez FF; Duyckaerts C; Mackenzie IR; Perry RH; Skullerud K; Yokoo H; Cairns NJ
J Neural Transm (Vienna); 2011 Nov; 118(11):1651-7. PubMed ID: 21792670
[TBL] [Abstract][Full Text] [Related]
3. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
Armstrong RA; Cairns NJ
Histol Histopathol; 2011 Feb; 26(2):185-90. PubMed ID: 21154232
[TBL] [Abstract][Full Text] [Related]
4. Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders.
Armstrong RA; Cairns NJ
J Neural Transm (Vienna); 2012 Dec; 119(12):1551-60. PubMed ID: 22678700
[TBL] [Abstract][Full Text] [Related]
5. Spatial patterns of TDP-43 neuronal cytoplasmic inclusions (NCI) in fifteen cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
Armstrong RA; Cairns NJ
Neurol Sci; 2011 Aug; 32(4):653-9. PubMed ID: 21647631
[TBL] [Abstract][Full Text] [Related]
6. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
[TBL] [Abstract][Full Text] [Related]
7. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies.
Koga S; Murakami A; Soto-Beasley AI; Walton RL; Baker MC; Castanedes-Casey M; Josephs KA; Ross OA; Dickson DW
Acta Neuropathol Commun; 2023 Jul; 11(1):109. PubMed ID: 37415197
[TBL] [Abstract][Full Text] [Related]
8. Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.
Mackenzie IR; Neumann M; Cairns NJ; Munoz DG; Isaacs AM
J Mol Neurosci; 2011 Nov; 45(3):402-8. PubMed ID: 21603977
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
Gittings LM; Foti SC; Benson BC; Gami-Patel P; Isaacs AM; Lashley T
Acta Neuropathol Commun; 2019 Feb; 7(1):18. PubMed ID: 30755280
[TBL] [Abstract][Full Text] [Related]
10. FUS pathology in basophilic inclusion body disease.
Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
[TBL] [Abstract][Full Text] [Related]
11. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration.
Davidson YS; Robinson AC; Flood L; Rollinson S; Benson BC; Asi YT; Richardson A; Jones M; Snowden JS; Pickering-Brown S; Lashley T; Mann DMA
Acta Neuropathol Commun; 2017 Jun; 5(1):54. PubMed ID: 28666471
[TBL] [Abstract][Full Text] [Related]
13. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.
Lashley T; Rohrer JD; Bandopadhyay R; Fry C; Ahmed Z; Isaacs AM; Brelstaff JH; Borroni B; Warren JD; Troakes C; King A; Al-Saraj S; Newcombe J; Quinn N; Ostergaard K; Schrøder HD; Bojsen-Møller M; Braendgaard H; Fox NC; Rossor MN; Lees AJ; Holton JL; Revesz T
Brain; 2011 Sep; 134(Pt 9):2548-64. PubMed ID: 21752791
[TBL] [Abstract][Full Text] [Related]
14. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
15. Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.
Davidson YS; Robinson AC; Hu Q; Mishra M; Baborie A; Jaros E; Perry RH; Cairns NJ; Richardson A; Gerhard A; Neary D; Snowden JS; Bigio EH; Mann DM
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):157-65. PubMed ID: 22497712
[TBL] [Abstract][Full Text] [Related]
16. Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants.
Lin LC; Nana AL; Hepker M; Hwang JL; Gaus SE; Spina S; Cosme CG; Gan L; Grinberg LT; Geschwind DH; Coppola G; Rosen HJ; Miller BL; Seeley WW
Acta Neuropathol Commun; 2019 Oct; 7(1):159. PubMed ID: 31640778
[TBL] [Abstract][Full Text] [Related]
17. Distinct pathological subtypes of FTLD-FUS.
Mackenzie IR; Munoz DG; Kusaka H; Yokota O; Ishihara K; Roeber S; Kretzschmar HA; Cairns NJ; Neumann M
Acta Neuropathol; 2011 Feb; 121(2):207-18. PubMed ID: 21052700
[TBL] [Abstract][Full Text] [Related]
18. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
[TBL] [Abstract][Full Text] [Related]
19. Reappraisal of TDP-43 pathology in FTLD-U subtypes.
Mackenzie IR; Neumann M
Acta Neuropathol; 2017 Jul; 134(1):79-96. PubMed ID: 28466142
[TBL] [Abstract][Full Text] [Related]
20. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
